Clinical Trial Results TV

Main Menu

Series

Duke Clinical Medicine
SCAI TV

Categories

Duke Clinical Medicine
	ACS: 17 submissions (showing 1 to 15)

| Page 1 | Page 2 |

Safety and Efficacy of Adjusted-Dose Eptifibatide in Patients With Acute Coronary Syndromes and Reduced Renal Function
Dr. Chiara Melloni

Dr. Robert Byrne and Dr. C. Michael Gibson discuss the ISAR-DESIRE 2 Trial
Dr. Robert Byrne, Dr. C. Michael Gibson

Dr. L. Kristin Newby, Dr. Robert Giugliano, and Dr. C. Michael Gibson discuss EARLY ACS
Dr. L. Kristin Newby, MD, Dr. Robert Giugliano, Dr. C. Michael Gibson

Novel Concepts in ACS: Combining Antithrombotic and Bleeding Outcomes
Dr. Christopher Granger, MD

Reperfusion Reflections
Dr. Paul W. Armstrong, MD

Diabetes Mellitus & Acute Coronary Syndromes
Mikael Dellborg. MD

Recent Advances in Antithrombotic Therapy Across the Spectrum of ACS
Dr. Marc Sabatine, MD

The Intersection of Acute Coronary Syndromes and Atherothrombosis in Contemporary Clinical Practice
Dr. Mark Feinglos, MD

Between Symptoms and the Hospital Door: What Works in Pre-Hospital Care?
Dr. Joseph P. Ornato, MD

How Can Computed Tomography and Magnetic Resonance Help You Care For Your Patients With ACS?
Dr. William Gregory Hundley, MD

ACS in the Era of Gluttony and Sloth: Considering the Metabolic Syndrome
Dr. Darren K. McGuire, MD

What Happens to the NSTEMI/ACS Patient in the Hospital?: Results from CRUSADE National QI Initiative
Dr. Eric D. Peterson, MD, MPH

Chest Pain Units: Handling Patients When You're Just Not Sure
Dr. James McCord, MD

In-hospital Care of STEMI
Dr. Eric Bates, MD

Risk Stratification in the Care of ACS: The Role of the ED in Matching Treatment to Risk in Cardiac Care
Dr. James Hoekstra, MD